Price T Rowe Associates Inc. MD Has $32.21 Million Stake in Bruker Co. (NASDAQ:BRKR)

Price T Rowe Associates Inc. MD raised its holdings in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 3.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 549,490 shares of the medical research company's stock after acquiring an additional 19,844 shares during the period. Price T Rowe Associates Inc. MD owned about 0.36% of Bruker worth $32,212,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Eagle Bay Advisors LLC boosted its holdings in Bruker by 2,324.1% in the 4th quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company's stock valued at $41,000 after purchasing an additional 674 shares in the last quarter. UMB Bank n.a. lifted its stake in shares of Bruker by 37.5% during the 4th quarter. UMB Bank n.a. now owns 909 shares of the medical research company's stock worth $53,000 after purchasing an additional 248 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Bruker by 47.5% during the 4th quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company's stock worth $75,000 after acquiring an additional 412 shares during the period. Quadrant Capital Group LLC raised its stake in Bruker by 18.2% during the fourth quarter. Quadrant Capital Group LLC now owns 1,273 shares of the medical research company's stock worth $75,000 after purchasing an additional 196 shares during the period. Finally, EverSource Wealth Advisors LLC raised its position in shares of Bruker by 41.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,330 shares of the medical research company's stock worth $78,000 after buying an additional 390 shares during the period. 79.52% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on BRKR shares. Barclays lowered their price target on shares of Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. Guggenheim reiterated a "buy" rating on shares of Bruker in a research note on Monday, February 24th. Citigroup lowered their target price on Bruker from $75.00 to $50.00 and set a "buy" rating for the company in a report on Monday, April 7th. Wells Fargo & Company cut their price target on Bruker from $75.00 to $60.00 and set an "overweight" rating on the stock in a report on Thursday, April 17th. Finally, Stifel Nicolaus lowered their price objective on Bruker from $70.00 to $57.00 and set a "hold" rating for the company in a research note on Friday, February 14th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $65.00.

Bruker Price Performance

Shares of NASDAQ:BRKR traded up $0.37 during trading on Monday, reaching $40.81. The company had a trading volume of 984,419 shares, compared to its average volume of 1,524,577. Bruker Co. has a twelve month low of $34.10 and a twelve month high of $79.78. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60. The firm has a market capitalization of $6.18 billion, a PE ratio of 53.55, a price-to-earnings-growth ratio of 2.16 and a beta of 1.23. The firm's fifty day moving average is $42.05 and its 200 day moving average is $51.83.

Bruker (NASDAQ:BRKR - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. On average, equities analysts forecast that Bruker Co. will post 2.69 EPS for the current year.

Bruker Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 28th. Stockholders of record on Monday, March 17th were given a dividend of $0.05 per share. The ex-dividend date of this dividend was Monday, March 17th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.49%. Bruker's dividend payout ratio (DPR) is presently 26.32%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.